Globeflex Capital L P Uni Qure N.V. Transaction History

Globeflex Capital L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $146,372 - $227,628	-11,131 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$14.54 - $21.5 $134,335 - $198,638	-9,239 Reduced 45.36%	11,131 $201,000
Q4 2021 Feb 10, 2022	SELL	$20.24 - $36.01 $435,767 - $775,295	-21,530 Reduced 51.38%	20,370 $422,000
Q3 2021 Nov 12, 2021	BUY	$26.01 - $38.22 $1.09 Million - $1.6 Million	41,900 New	41,900 $1.34 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.